GLP-1 Price Tracker 2026: What Men Are Actually Paying Month-by-Month

Updated March 2026 • 10 min read • Prices verified monthly

The GLP-1 Pricing Reality in 2026

The GLP-1 pricing landscape for men has shifted dramatically since these medications first gained mainstream attention. Here's the honest picture as of March 2026:

The good news: Competition among telehealth providers has driven compounded GLP-1 pricing to its lowest levels ever. The number of providers offering compounded semaglutide and tirzepatide has more than tripled since 2024, and price pressure is real. Some promotional offers dip below $150/month for semaglutide.

The bad news: Brand-name pricing hasn't budged. Novo Nordisk's Wegovy and Eli Lilly's Zepbound still carry list prices that are inaccessible without good insurance. Medicare negotiation is underway but hasn't produced pharmacy-level savings yet. And the FDA's regulatory stance on compounded semaglutide introduces ongoing uncertainty — if compounding eligibility changes, millions of men could face sudden price increases.

The bottom line: Most men in 2026 are accessing GLP-1 therapy through telehealth providers offering compounded medications at $150–$400/month. This guide breaks down exactly what every option costs, what you get for the money, and how to minimize your spending without compromising quality.

Compounded GLP-1 Pricing: Where 80% of Men Start

Compounded semaglutide and tirzepatide are prepared by 503A or 503B compounding pharmacies and dispensed through telehealth platforms. They contain the same active ingredient as the brand-name versions but are produced in different facilities under different regulatory frameworks.

Compounded Semaglutide Monthly Pricing (March 2026)

Compounded Tirzepatide Monthly Pricing (March 2026)

Tirzepatide generally costs $50–$100/month more than semaglutide through the same providers, reflecting higher raw material costs and more complex compounding. Expect:

Brand-Name Pricing: The Insurance Question

The arithmetic is straightforward: if you have employer-sponsored insurance that covers GLP-1 medications for weight management, brand-name is almost always cheaper than compounded. Many large employers (especially in tech, finance, and healthcare) have added obesity medication coverage in the past two years.

If you don't have coverage — and roughly 60% of men don't for weight loss specifically — compounded is the rational economic choice by a factor of 3–5x.

Oral Semaglutide Pricing

Oral semaglutide is a growing category with distinct pricing dynamics:

Several providers now offer compounded oral semaglutide — see our full oral semaglutide guide for provider comparisons and what to expect from the oral route. Breeze Meds is one provider making a play in this space.

Hidden Costs Men Don't Expect

The monthly medication cost is the biggest line item, but it's not the only one. Here's what men often miss when budgeting for GLP-1 treatment:

Initial consultation fees: Some providers charge $50–$149 upfront for the initial medical evaluation, separate from the monthly medication cost. Others roll it into the first month. Ask before signing up.

Lab work: Comprehensive bloodwork (metabolic panel, lipids, A1C, testosterone, thyroid) typically costs $100–$300 if your provider requires it and doesn't include it. Many telehealth providers skip labs entirely; premium providers like MEDVi include regular lab monitoring in their monthly fee. For men, testosterone testing is particularly valuable — it quantifies the hormonal benefit of weight loss.

Supplies: Injectable GLP-1s require syringes, alcohol swabs, and sharps disposal containers. Most providers include supplies, but some don't. Budget $10–$20/month if buying separately.

Dose escalation: Most men start at low doses and titrate up over 4–8 weeks. Some providers charge the same monthly rate regardless of dose; others increase pricing as your dose increases. Clarify the dose-pricing relationship before committing.

The protein tax: This isn't a medical cost, but it's real. GLP-1 medications suppress appetite significantly, and the biggest risk for men is losing muscle along with fat. Protecting lean mass requires 120–180g of protein daily, which often means protein supplements ($50–$100/month) and higher grocery bills. Factor this into your total monthly budget — your results depend on it. See our protein-first diet protocol for specifics.

Gym membership: If you're not already lifting, you should be. Resistance training during GLP-1 therapy isn't optional — it's essential for muscle preservation and long-term metabolic health. Budget $30–$80/month for a gym that has free weights. Our 3-day lifting program is designed specifically for men on GLP-1 therapy.

Provider-by-Provider Comparison

*Promotional/introductory pricing; verify current rates. All prices approximate as of March 2026.

Insurance Coverage in 2026: What's Changed

Insurance coverage for GLP-1 medications has improved but remains inconsistent. Here's the current landscape for men:

Employer-sponsored plans: Approximately 40–50% of large employer plans now cover GLP-1 medications for weight management (up from roughly 25% in 2024). Tech companies, financial institutions, and healthcare systems lead coverage expansion. If your employer covers it, your out-of-pocket cost drops to $25–$150/month for brand-name medication — significantly cheaper than compounded.

Medicare: The Treat and Reduce Obesity Act made GLP-1 medications covered under Medicare Part D for obesity treatment, beginning in phases through 2025-2026. However, implementation has been uneven, and prior authorization requirements can delay access. If you're Medicare-eligible, see our insurance and Medicare guide for step-by-step navigation. Zealthy (check availability) specifically positions themselves to help patients navigate insurance coverage.

ACA marketplace plans: Coverage varies widely by state and plan tier. Generally, Silver and Gold plans are more likely to cover obesity medications than Bronze plans. Check your formulary before open enrollment.

VA healthcare: The VA has been increasingly prescribing GLP-1 medications for eligible veterans with obesity. If you're a veteran, this is worth pursuing — the VA formulary often provides medications at minimal or no cost.

Cost Reduction Strategies That Actually Work

Strategy 1: Insurance appeal. If your insurance denies coverage, appeal. Formal appeals with supporting documentation from your physician succeed approximately 30–40% of the time. Include BMI documentation, comorbidity diagnoses (diabetes, hypertension, sleep apnea), and a letter of medical necessity.

Strategy 2: Manufacturer savings programs. Both Novo Nordisk (for Wegovy) and Eli Lilly (for Zepbound) offer savings cards that can reduce costs for commercially insured patients. These don't help the uninsured, but if you have insurance that partially covers GLP-1s, they can eliminate or reduce your copay.

Strategy 3: Health Savings Account (HSA) / Flexible Spending Account (FSA). Both compounded and brand-name GLP-1 medications are HSA/FSA-eligible when prescribed by a licensed provider. This effectively reduces your cost by your marginal tax rate — 22–37% for most men. A $300/month medication becomes $186–$234/month after tax savings.

Strategy 4: Dose optimization. Not every man needs the maximum dose. Some men achieve their goals at maintenance doses (semaglutide 1mg instead of 2.4mg, for example), which can reduce medication costs by 30–50% through lower-dose vials. Discuss dose optimization with your provider once you've reached your target weight.

Strategy 5: Provider comparison shopping. Pricing varies significantly between telehealth platforms, and competitive pressure means many providers will match or beat competitor pricing if asked. Don't be loyal to a provider charging $100/month more than the competition for the same medication.

The Value Calculation: What Weight Loss Is Actually Worth

Before you decide $200–$400/month is "too expensive," consider what excess weight actually costs you:

Direct medical costs: Obesity-related healthcare costs average $1,861/year more than normal-weight individuals in the US. For men with obesity-related comorbidities (diabetes, hypertension, sleep apnea), the differential is $3,000–$5,000+/year.

Lost earnings: Multiple studies have documented an "obesity wage penalty" — men with obesity earn 3–6% less than normal-weight counterparts, controlling for education and experience. For a man earning $80,000/year, that's $2,400–$4,800/year in lost income.

Life insurance: Men with BMI > 30 pay 20–50% more for life insurance. If you're paying $150/month for a $1M term policy, obesity could be costing you $30–$75/month in premium differential.

Quality-adjusted life years: Obesity reduces life expectancy by 5–14 years and significantly reduces quality of life in the years you do have. You can't put a monthly price on that, but you can recognize that $200–$400/month for a medication that addresses it is one of the highest-ROI health investments available.

For comprehensive pricing data across every GLP-1 provider and medication, visit our partner site GLP-1PriceList.com — the most detailed pricing comparison resource available.